Takeda sweetens the pill for Shire with $64 billion takeover offer

Rare disease specialist Shire says it is willing to recommend a sweetened $64 billion offer from Japan's Takeda Pharmaceutical Co to shareholders, in what would be the biggest acquisition of a drug company this year. Silvia Antonioli reports.

Save videos for later by signing up or logging in

With "My Queue" you can quickly save videos to watch later.

To add an item to your queue just click the sign next to the video.

Once you've added a video visit "My Queue" to start watching!